4Simes RJ,Topol E J,Holmes DR Jr,et al.Link between the angiographic substudy and mortality outcomes in a large randomized trial of myocardial reperfusion.Importance of early and complete infarct artery reperfusion.GUSTO-Ⅰ Investigators.Circulation,1995,91:1923-1928.
5Reffelmann T,Kloner RA.The "no-reflow" phenomenon:basic science and clinical correlates.Heart,2002,87:162-168.
6Resnic FS,Wainstein M,Lee MK,et al.No-reflow is an independent predictor of death and myocardial infarction after percutaneous coronary intervention.Am Heart J,2003,145:42-46.
7Wong VW,Ross DL,Park K,et al.Hyperglycemia:still an important predictor of adverse outcomes following AMI in the reperfusion era.Diabetes Res Clin Pract,2004,64:85-91.
8Malmberg K,Ryden L,Efendic S,et al.Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study):effects on mortality at 1 year.J Am Coll Cardiol,1995,26:57-65.
9Morishima I,Sone T,Okumura K,et al.Angiographic no-reflow phenomenon as a predictor of adverse long-term outcome in patients treated with percutaneous transluminal coronary angioplasty for first acute myocardial infarction.J Am Coll Cardiol,2000,36:1202-1209.
10Furber AP,Prunier F,Nguyen HC,et al.Coronary blood flow assessment after successful angioplasty for acute myocardial infarction predicts the risk of long-term cardiac events.Circulation,2004,110:3527-3533.
